On 18 November 2024, GenAI Summit was held at Stavros Niarchos Cultural Centre, where the project jointly developed or with UBITECH was presented, strengthening the dynamics of the GeneAI in Pharmaceutical Industry. In particular, VIANEX and UBITECH work together to develop an advanced digital assistant GenAI, adapted to the employees of VIANEX factory I and designed to streamline critical functions, improve crisis management efficiency and prevent damage. Dimitris Giannakopoulos, Chairman of the Board and CEO of VIANEX, said on the occasion of the collaboration: “At the heart of VIANEX’s activity and new collaborations is man. Our cooperation with the leading company in the field of UBITECH technology, as well as any next step in the history of 100 years of the company’s presence, aims to optimize the working conditions of employees, which can lead to productive development and a better final result. Following rapid technological development, we use it for the benefit of improving production and human beings. “ Essentially, the use of the capabilities of digital AI assistant at the A’ plant of VIANEX improves operational efficiency, reduces shutdown time and supports employees in their daily work, optimising production processes and minimizing risks. As stated by Mr Emmanuel Avgerinos, Director-General of VIANEX factory: “Our collaboration with UBITECH boosted the factory A’ of VIANEX with an artificial intelligence solution, strengthening our operational efficiency and ensuring that higher quality and regulatory standards are respected. This innovative approach not only optimizes productivity but also aligns with our commitments to Environmental, Social and Corporate Governance. We are very happy for cooperation, as it sets a new standard in innovation and efficiency, paving the way for further developments in the digital transformation of pharmaceutical production.” Dr. Panayiotis Gouvas, Research & Development Director of UBITECH, then stated: “We are particularly proud of our cooperation with VIANEX, Greece’s largest pharmaceutical company, with the ultimate goal of exploiting the transformative potential of GenericAI in the pharmaceutical industry. The purpose of cooperation lies precisely in the fact that through technology, rationalisation of functions, strengthening compliance and preventing errors in the production process can be strengthened. We hope that through the development of the advanced digital assistant the company’s operational efficiency for more valid and detailed results will be achieved. “ GenAI Summit is the largest conference in the Southeastern Mediterranean region that focuses exclusively on GenAI and is organised with the support of the European Investment Bank, the Office for the Interconnection of the European Parliament, the Greek Development Bank and the Greek Investment Development Bank, under the auspices of the Ministry of Digital Governance.
VIANEX and UBITECH Group pave the way for digital transformation of pharmaceutical industry
—
in Greece